Open Access
| Issue |
BIO Web Conf.
Volume 55, 2022
5th International Conference on Frontiers of Biological Sciences and Engineering (FBSE 2022)
|
|
|---|---|---|
| Article Number | 01021 | |
| Number of page(s) | 4 | |
| DOI | https://doi.org/10.1051/bioconf/20225501021 | |
| Published online | 21 November 2022 | |
- Xu Qinghua, Zhuang Fuchun, Chen Chongyi. Effect of high-throughput hemodialysis on cardiac function in patients with end-stage renal disease [J]. Journal of Rational Drug Use,2021,14 (27):173-174+177. [Google Scholar]
- Liu S, Liu H, Wang Z, et al. Effect of changing treatment to high-flux hemodialysis (observation group) on mortality in patients with long-term low flux hemodialysis (LFHD): a propensity score matched cohort study[J]. BMC nephrology, 2020, 21(1): 1-6. [CrossRef] [Google Scholar]
- Saran R, Robinson B, Abbott K C, et al. US renal data system 2016 annual data report: epidemiology of kidney disease in the United States[J]. American journal of kidney diseases, 2017, 69(3): A7-A8. [CrossRef] [PubMed] [Google Scholar]
- National Institutes of Health. United States Renal Data System 2011 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States[J]. National Institutes of Health: National Institute of Diabetes and Digestive and Kidney Diseases, 2011. [Google Scholar]
- National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. United States Renal Data System. 2017 USRDS annual data report: Epidemiology of kidney disease in the United States[J]. 2017. [Google Scholar]
- Lin W H, Yang C Y, Kuo S, et al. Hepatic and cardiovascular safety of acarbose among type 2 diabetes patients with end-stage renal disease: A nationwide population-based longitudinal study[J]. Diabetes Research and Clinical Practice, 2021, 172: 108489. [CrossRef] [PubMed] [Google Scholar]
- Ng M S N, So W K W, Wong C L, et al. Stability and impact of symptom clusters in patients with endstage renal disease undergoing dialysis[J]. Journal of pain and symptom management, 2020, 59(1): 67-76. [CrossRef] [PubMed] [Google Scholar]
- Kato S, Chmielewski M, Honda H, et al. Aspects of immune dysfunction in end-stage renal disease[J]. Clinical Journal of the American Society of Nephrology, 2008, 3(5): 1526-1533. [CrossRef] [PubMed] [Google Scholar]
- Lee S H, Lin Y C, Chang C J, et al. Outcome and cost analysis of primary total knee arthroplasty in end-stage renal disease patients: A nationwide population-based study[J]. Biomedical journal, 2020. [PubMed] [Google Scholar]
- Maduell F, Moreso F. Should high-flux hemodialysis be replaced by online hemodiafiltration for treating end-stage renal disease patients? [J]. Journal of comparative effectiveness research, 2013, 2(4): 347-349. [CrossRef] [PubMed] [Google Scholar]
- Xue Lanfen, Nie Limin, Yan Kang, Zhang Guoxin, Liu Na, Niu Wenming. Clinical efficacy of highthroughput hemodialysis in the treatment of endstage renal failure [J]. Chin J Clin Exp,2017,30(02):188-190. [Google Scholar]
- Liu Xiaobin, Wang Liang, Liu Bin, You Yuwang, Zhang Zhijian, Chen Yong, Sun Zhuxing. Effect of high-throughput hemodialysis on insulin resistance and microinflammation in elderly patients with diabetic nephropathy [J]. Chin J Geriatrics, 2014, 33(02):159-162. [Google Scholar]
- LIU W. Clinical efficacy of high-throughput hemodialysis in the treatment of end-stage renal failure [J]. Big doctor, 2018, 3 (9): 89-90. [Google Scholar]
- Shao Jieying, Lu Yiming, Li Xiaohui. Analysis of high-throughput hemodialysis in the treatment of severe renal failure [J]. Chin J General Practice, 2011, 9(05):742-743. [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.